Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...

New research has found that persons living with breast, lung, bowel and liver cancers who take GLP-1 weight-loss drugs may be ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic improvements associated with this class of medications.

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

Oral cancer in India is often diagnosed late due to symptom normalization among tobacco users, complicating treatment and ...

Scientists at ARI, Pune, developed a biodegradable nanomedicine that targets breast cancer cells, silences key survival genes ...

Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3 ...